Skip to content

Bdprobetec Et Chlamydia Trachomatis and Neisseria Gonorrhoeae Amplified DNA Assay

by Becton Dickinson Microbiology Systems

510(k) K984631

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None ongoing

2 closed

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 11 Oct 2026. What this means

Regulatory status

as of registry sync 11 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK984631 Date4 Nov 1999ClearedStatusActive

Recalls

2 recalls · FDA

    • Terminated Z-2658-2011 FDA Unclassified (pre-2012) initiated 29 Sep 2010 on shared 510(k) K984631

    In vitro diagnostic reagent packs may be underfilled and contribute to invalid quality control testing or false positive patient results.

    • Terminated Z-1094-03 FDA Unclassified (pre-2012) initiated 21 Jul 2003

    Component of in vitro diagnostic device was incorrectly installed causing incorrect reporting of patient results.

Recalls on a shared submission name another device cleared under the same FDA submission as this one.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
LSL
Device Class
Class II
Regulation
21 CFR Part 866.3390
Advisory Committee
Microbiology
FDA Decision
SESE Substantially Equivalent

Other devices from Becton Dickinson Microbiology Systems

See all devices from Becton Dickinson Microbiology Systems →